Skip to main content
. 2020 Feb 17;12(4):273–281. doi: 10.1080/21541248.2020.1728469

Figure 1.

Figure 1.

Effect of selective PI3K inhibitors on melanoma cell viability. Melanoma cells were treated for 72 h with concentrations ranging from 0.01 µM to 0.5 µM of (a) pan-PI3K (BKM120), (b) PI3Kα (BYL719), (c) PI3Kβ (TGX221), (d) PI3Kβ (GSK2636771), (e) PI3Kγ (AS252424), (f) PI3Kδ (GSK2269557). Cell viability was determined by an MTT assay. Data represent the mean (SD) of three independent experiments